Merit Financial Group, LLC Ironwood Pharmaceuticals Inc Transaction History
Merit Financial Group, LLC
- $6.49 Billion
- Q1 2025
A detailed history of Merit Financial Group, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Merit Financial Group, LLC holds 15,322 shares of IRWD stock, worth $13,636. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,322Holding current value
$13,636% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
238Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$20.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$17.4 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$14.6 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$10.4 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$8.43 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $136M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...